News

Objective Long-term azithromycin treatment effectively prevents acute exacerbations of chronic obstructive pulmonary disease ...
Women aged 40 years and older have a 50% greater risk for chronic obstructive pulmonary disease (COPD) vs men in the same age group, according to study findings published in BMJ Open Respiratory ...
Sue’s recommendation to others living with COPD is to not isolate yourself and stay at home. It is okay to ask for help and ...
The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...
Chronic obstructive pulmonary disease (COPD) affects 25 million people in the U.S. and is the fifth leading cause of death ...
It is becoming increasingly recognized that people with COPD have an elevated risk of serious CV events,1 discussed Hanania ...
Hospital admissions were reduced by more than 50% in the intervention group (P < .001), highlighting the potential of structured home-based care to break the cycle of frequent exacerbations in ...
Session ID: 2025-07-02:7941e9e72a60f8c5ca1a3b31 Player Element ID: vjs_video_3 ...
New study results with GSK's anti-IL-5 antibody Nucala in chronic obstructive pulmonary disease (COPD) have been published, just ahead of an FDA decision on the new indication scheduled for 7th May.
Federal appeals court denies Trump administration's request to halt injunction blocking Department of Education dismantling plans, which would reduce staff by half.
NBEMS has declared the GPAT 2025 result on natboard.edu.in. Candidates can download the merit list PDF and check their roll number, marks, and rank in the entrance exam.
Chronic obstructive pulmonary disease (COPD) has seen no new therapies brought to market for around 10 years – and now there have been two in the space of a couple of weeks.